NASDAQ:MTEM

Molecular Templates News Headlines

$8.25
+0.38 (+4.83 %)
(As of 04/14/2021 03:59 PM ET)
Add
Compare
Today's Range
$7.91
Now: $8.25
$8.62
50-Day Range
$7.82
MA: $11.12
$12.70
52-Week Range
$7.51
Now: $8.25
$18.44
Volume57,019 shs
Average Volume451,723 shs
Market Capitalization$462.43 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08

Headlines

Molecular Templates (NASDAQ MTEM) News Headlines Today

SourceHeadline
Target N. V. Biotech Acquires 50,000 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) StockTarget N. V. Biotech Acquires 50,000 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) Stock
americanbankingnews.com - April 13 at 5:02 PM
Molecular Templates Announces Poster Presentations on its Engineered Toxin Bodies at the American Association of Cancer Research (AACR) Virtual Annual Meeting IMolecular Templates Announces Poster Presentations on its Engineered Toxin Bodies at the American Association of Cancer Research (AACR) Virtual Annual Meeting I
finance.yahoo.com - April 12 at 7:27 AM
Molecular Templates, Inc. (NASDAQ:MTEM) Major Shareholder Target N. V. Biotech Acquires 500,000 SharesMolecular Templates, Inc. (NASDAQ:MTEM) Major Shareholder Target N. V. Biotech Acquires 500,000 Shares
americanbankingnews.com - April 9 at 4:12 PM
Jefferies Financial Group Weighs in on Molecular Templates, Inc.s FY2021 Earnings (NASDAQ:MTEM)Jefferies Financial Group Weighs in on Molecular Templates, Inc.'s FY2021 Earnings (NASDAQ:MTEM)
americanbankingnews.com - April 8 at 8:06 AM
Molecular Templates, Inc. (NASDAQ:MTEM) Major Shareholder Buys $1,888,000.00 in StockMolecular Templates, Inc. (NASDAQ:MTEM) Major Shareholder Buys $1,888,000.00 in Stock
americanbankingnews.com - April 7 at 1:38 PM
Stock Traders Buy Large Volume of Molecular Templates Call Options (NASDAQ:MTEM)Stock Traders Buy Large Volume of Molecular Templates Call Options (NASDAQ:MTEM)
americanbankingnews.com - April 7 at 6:52 AM
Jefferies Financial Group Boosts Molecular Templates (NASDAQ:MTEM) Price Target to $20.00Jefferies Financial Group Boosts Molecular Templates (NASDAQ:MTEM) Price Target to $20.00
americanbankingnews.com - April 6 at 3:28 PM
Molecular Templates (NASDAQ:MTEM) Stock Price Down 5.6%Molecular Templates (NASDAQ:MTEM) Stock Price Down 5.6%
americanbankingnews.com - April 6 at 1:02 PM
Molecular Templates (NASDAQ:MTEM) Shares Gap Down to $12.44Molecular Templates (NASDAQ:MTEM) Shares Gap Down to $12.44
americanbankingnews.com - April 5 at 11:40 AM
BRIEF-Molecular Templates Inc Says To Prioritize Next-Generation Etb CandidatesBRIEF-Molecular Templates Inc Says To Prioritize Next-Generation Etb Candidates
msn.com - April 5 at 9:13 AM
Molecular Templates, Inc. (NASDAQ:MTEM) Expected to Post Quarterly Sales of $29.66 MillionMolecular Templates, Inc. (NASDAQ:MTEM) Expected to Post Quarterly Sales of $29.66 Million
americanbankingnews.com - April 4 at 4:00 AM
 Analysts Expect Molecular Templates, Inc. (NASDAQ:MTEM) Will Announce Earnings of -$0.43 Per Share Analysts Expect Molecular Templates, Inc. (NASDAQ:MTEM) Will Announce Earnings of -$0.43 Per Share
americanbankingnews.com - April 2 at 4:32 AM
Target N. V. Biotech Acquires 80,000 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) StockTarget N. V. Biotech Acquires 80,000 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) Stock
americanbankingnews.com - March 31 at 4:50 PM
Molecular Templates, Inc. (NASDAQ:MTEM) Expected to Earn Q1 2021 Earnings of $0.75 Per ShareMolecular Templates, Inc. (NASDAQ:MTEM) Expected to Earn Q1 2021 Earnings of $0.75 Per Share
americanbankingnews.com - March 22 at 1:16 AM
Equities Analysts Set Expectations for Molecular Templates, Inc.s Q1 2021 Earnings (NASDAQ:MTEM)Equities Analysts Set Expectations for Molecular Templates, Inc.'s Q1 2021 Earnings (NASDAQ:MTEM)
americanbankingnews.com - March 22 at 1:16 AM
Upgrade: Analysts Just Made A Dazzling Increase To Their Molecular Templates, Inc. (NASDAQ:MTEM) ForecastsUpgrade: Analysts Just Made A Dazzling Increase To Their Molecular Templates, Inc. (NASDAQ:MTEM) Forecasts
finance.yahoo.com - March 21 at 9:42 AM
What You Need To Know About The Molecular Templates, Inc. (NASDAQ:MTEM) Analyst Downgrade TodayWhat You Need To Know About The Molecular Templates, Inc. (NASDAQ:MTEM) Analyst Downgrade Today
nasdaq.com - February 21 at 12:27 PM
Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of CancerMolecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer
finance.yahoo.com - February 11 at 10:10 AM
Investors Who Bought Molecular Templates (NASDAQ:MTEM) Shares Three Years Ago Are Now Up 41%Investors Who Bought Molecular Templates (NASDAQ:MTEM) Shares Three Years Ago Are Now Up 41%
finance.yahoo.com - February 8 at 1:27 PM
Stock Alert: Molecular Template Up 10%Stock Alert: Molecular Template Up 10%
nasdaq.com - February 2 at 2:16 PM
MTEM Feb 2021 10.000 callMTEM Feb 2021 10.000 call
uk.finance.yahoo.com - January 25 at 5:47 PM
MTEM Jan 2021 17.500 putMTEM Jan 2021 17.500 put
uk.finance.yahoo.com - January 7 at 9:49 PM
Molecular Templates, Inc. Provides Update on MT-5111 Phase 1 StudyMolecular Templates, Inc. Provides Update on MT-5111 Phase 1 Study
finance.yahoo.com - December 21 at 6:08 PM
Is MTEM A Good Stock To Buy Now According To Hedge Funds?Is MTEM A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 19 at 12:03 AM
Molecular Templates Inc.Molecular Templates Inc.
marketwatch.com - December 9 at 10:24 PM
Molecular Templates: Progress Stalled As Partial Hold Placed On Pivotal ETB TrialMolecular Templates: Progress Stalled As Partial Hold Placed On Pivotal ETB Trial
seekingalpha.com - November 17 at 2:30 PM
US$17.40: Thats What Analysts Think Molecular Templates, Inc. (NASDAQ:MTEM) Is Worth After Its Latest ResultsUS$17.40: That's What Analysts Think Molecular Templates, Inc. (NASDAQ:MTEM) Is Worth After Its Latest Results
finance.yahoo.com - November 8 at 12:25 PM
Molecular Templates EPS beats by $0.08, misses on revenueMolecular Templates EPS beats by $0.08, misses on revenue
seekingalpha.com - November 5 at 6:44 PM
Molecular Templates to Participate in September Virtual Investor ConferencesMolecular Templates to Participate in September Virtual Investor Conferences
finance.yahoo.com - September 3 at 8:13 AM
Did Hedge Funds Make The Right Call On Molecular Templates, Inc. (MTEM)Did Hedge Funds Make The Right Call On Molecular Templates, Inc. (MTEM)
finance.yahoo.com - August 12 at 12:45 PM
Did Hedge Funds Make The Right Call On Molecular Templates, Inc. (MTEM) ?Did Hedge Funds Make The Right Call On Molecular Templates, Inc. (MTEM) ?
finance.yahoo.com - August 12 at 12:45 PM
Molecular Templates EPS misses by $0.32, beats on revenueMolecular Templates EPS misses by $0.32, beats on revenue
seekingalpha.com - August 7 at 4:55 AM
Is Molecular Templates, Inc. (MTEM) A Good Stock To Buy?Is Molecular Templates, Inc. (MTEM) A Good Stock To Buy?
finance.yahoo.com - June 24 at 5:23 PM
Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2020 Highlight Evolution of ETB PlatformMolecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2020 Highlight Evolution of ETB Platform
finance.yahoo.com - June 22 at 7:44 AM
Molecular Templates announces ~9.44M share offeringMolecular Templates announces ~9.44M share offering
seekingalpha.com - June 5 at 10:13 AM
Molecular Templates EPS misses by $0.21, misses on revenueMolecular Templates EPS misses by $0.21, misses on revenue
seekingalpha.com - May 11 at 5:34 PM
Molecular Templates, Inc. Reports First Quarter 2020 Financial ResultsMolecular Templates, Inc. Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 11 at 5:34 PM
Molecular Templates EPS misses by $0.19, beats on revenueMolecular Templates EPS misses by $0.19, beats on revenue
seekingalpha.com - March 12 at 8:59 PM
Molecular Templates up 8% on ETB advancementMolecular Templates up 8% on ETB advancement
seekingalpha.com - February 19 at 1:24 PM
Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple MyelomaMolecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma
finance.yahoo.com - February 19 at 8:23 AM
Austin biotech firm Molecular Templates pushes ahead with new fundingAustin biotech firm Molecular Templates pushes ahead with new funding
www.msn.com - November 29 at 5:29 PM
Molecular Templates to Present at Two December Investor ConferencesMolecular Templates to Present at Two December Investor Conferences
finance.yahoo.com - November 26 at 3:30 PM
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks Positive Readout, Enanta Misses Earnings EstimateThe Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate
www.benzinga.com - November 22 at 8:58 AM
Molecular Templates, Inc. Announces Proposed Public Equity OfferingMolecular Templates, Inc. Announces Proposed Public Equity Offering
finance.yahoo.com - November 20 at 6:37 PM
Vertex teams up with Molecular Templates in HSCT conditioning regimensVertex teams up with Molecular Templates in HSCT conditioning regimens
seekingalpha.com - November 18 at 12:44 PM
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell TransplantsVertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
finance.yahoo.com - November 18 at 7:44 AM
Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111
finance.yahoo.com - November 14 at 8:13 AM
Molecular Templates EPS of $1.03Molecular Templates EPS of $1.03
seekingalpha.com - November 12 at 6:03 PM
What Kind Of Shareholders Own Molecular Templates, Inc. (NASDAQ:MTEM)?What Kind Of Shareholders Own Molecular Templates, Inc. (NASDAQ:MTEM)?
finance.yahoo.com - October 28 at 8:14 PM
Molecular Templates: Pipeline Progressing, Clinical Updates LoomMolecular Templates: Pipeline Progressing, Clinical Updates Loom
seekingalpha.com - September 26 at 5:14 PM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.